Brief: Deciphera Pharmaceuticals Announces Planned 2023 Corporate Milestones

Deciphera Pharmaceuticals

03/01/2023 21:37

Jan 3 (Reuters) - Deciphera Pharmaceuticals Inc
 DCPH.O :
    * DECIPHERA PHARMACEUTICALS ANNOUNCES PLANNED 2023 CORPORATE
MILESTONES TO SUPPORT CONTINUED EVOLUTION TO MULTI-PRODUCT
COMPANY
    * DECIPHERA PHARMACEUTICALS INC - PRELIMINARY UNAUDITED
REVENUE OF
APPROXIMATELY $36 MILLION FOR Q4 2022
    * DECIPHERA PHARMACEUTICALS INC - EXPECTS TO COMPLETE
ENROLLMENT
IN PHASE 3 MOTION STUDY OF VIMSELTINIB IN H1 2023 AND ANNOUNCE
TOP-LINE RESULTS IN Q4 2023
    * DECIPHERA PHARMACEUTICALS INC - CURRENT CASH, CASH
EQUIVALENTS,
MARKETABLE SECURITIES AND OTHERS TO FUND OPERATING, CAPITAL
EXPENDITURES INTO 2025

Source text for Eikon:  ID:nBw2skkwNa 
Further company coverage:  DCPH.O 
 ((Reuters.Briefs@thomsonreuters.com;))